Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23497)

• Formulation Name: Ondansetron Hydrochloride eq 4mg base tablet
• Company: Rpk Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ondansetron	(DMOTQ1I)	Chemotherapy-induced nausea	MD90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Hypromellose	(E00634)	Not Available	Coating agent
Magnesium stearate	(E00208)	11177	lubricant
Pregelatinized starch	(E00674)	Not Available	Binding agent; Diluent; Disintegrant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent